About ValTech Lifesciences
ValTech Lifesciences is a company based in Bern (Switzerland) founded in 2024. ValTech Lifesciences has raised $176.38 thousand across 1 funding round from investors including Venture Kick. ValTech Lifesciences operates in a competitive market with competitors including Atraverse Medical, Auflows CardioTech, CardioPrecision, Helios Cardio and Saint Medical, among others.
- Headquarter Bern, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$176.38 K (USD)
in 1 rounds
-
Latest Funding Round
$176.38 K (USD), Seed
Sep 23, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ValTech Lifesciences
ValTech Lifesciences has successfully raised a total of $176.38K through 1 strategic funding round. The most recent funding activity was a Seed round of $176.38 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ValTech Lifesciences
ValTech Lifesciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for ValTech Lifesciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ValTech Lifesciences
Investment portfolio details for ValTech Lifesciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ValTech Lifesciences
Detailed financials for ValTech Lifesciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Valtech Lifesciences Comparisons
Peer comparison for ValTech Lifesciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ValTech Lifesciences
ValTech Lifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atraverse Medical, Auflows CardioTech, CardioPrecision, Helios Cardio and Saint Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation tools for left-heart access are developed for cardiac treatments.
|
|
| Locked | Locked | Locked |
Provider of cardiovascular medical devices and surgical solutions for pediatric patients
|
|
| Locked | Locked | Locked |
Developer of medical devices for the less invasive treatment of structural heart disease
|
|
| Locked | Locked | Locked |
Develops biologic matrices for cardiac repair and regeneration of heart conditions.
|
|
| Locked | Locked | Locked |
Medical devices for invasive cardiovascular surgery are developed.
|
Detailed competitors of ValTech Lifesciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Valtech Lifesciences
Complete news archive for ValTech Lifesciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ValTech Lifesciences
ValTech Lifesciences was founded in 2024.
ValTech Lifesciences is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.
ValTech Lifesciences is a funded company, having raised a total of $176.38K across 1 funding round to date.
ValTech Lifesciences was founded in 2024 in Bern, Switzerland, within the medical devices sector. Operations focus on engineering-based valve prostheses that incorporate fluid mechanics and cardiovascular principles. These devices are designed to address thrombogenicity issues in mechanical implants for cardiac procedures. Services include development and provision of such prostheses to support surgical applications in the cardiovascular field.
ValTech Lifesciences's top competitors include Atraverse Medical, CardioPrecision and Auflows CardioTech.
ValTech Lifesciences has 1 investor. Key investors include Venture Kick.